Skip to main content
. 2018 Feb 20;109(3):678–687. doi: 10.1111/cas.13493

Table 1.

Details of clinical prostate cancer specimens

Pca type Age (y) Gleason score Time for ADT (mo)
Initial Pca 70.8 ± 10.0 7.0 ± 1.0 0
CRPC 79.8 ± 2.6 8.2 ± 0.8 56.0 ± 23.6

ADT, androgen‐deprivation therapy; CRPC, castration‐resistant prostate cancer; PCa prostate cancer.